Osteoporosis after solid organ and bone marrow transplantation

被引:124
作者
Cohen, A [1 ]
Shane, E [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
关键词
bisphosphonates; cyclosporine; fracture; glucocorticoids; osteoporosis; tacrolimus; transplantation;
D O I
10.1007/s00198-003-1426-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Organ transplantation has become increasingly common as a therapy for end-stage renal, liver, cardiac and pulmonary disease. The population of patients who have survived organ transplantation has grown dramatically over the last 2 decades. Although organ transplant recipients now benefit from greatly improved survival, long-term complications of organ transplantation, such as osteoporosis, adversely affect quality of life and must be addressed. In the early posttransplantation period, the effects of high dose glucocorticoids, combined with other immunosuppressive drugs such as cycosporine A and tacrolimus, cause rapid bone loss particularly at the spine and proximal femur. In this setting, fracture incidence rates as high as 25-65% have been reported. Treatment and prevention strategies must target this early post-transplant period, as well as the patient awaiting transplantation and the long-term transplant recipient. This review will discuss the clinical features of transplantation osteoporosis, the pathophysiology of post-transplantation bone loss and prevention and therapy of this unique bone disease.
引用
收藏
页码:617 / 630
页数:14
相关论文
共 182 条
[1]   Bone mineral status in end-stage liver disease and the effect of liver transplantation [J].
Abdelhadi, M ;
Eriksson, SAV ;
Eriksson, SL ;
Ericzon, BG ;
Nordenstrom, J .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 (12) :1210-1215
[2]   LOSS OF REGIONAL BONE-MINERAL DENSITY IN THE 1ST 12 MONTHS FOLLOWING RENAL-TRANSPLANTATION [J].
ALMOND, MK ;
KWAN, JTC ;
EVANS, K ;
CUNNINGHAM, J .
NEPHRON, 1994, 66 (01) :52-57
[3]   High turnover bone disease following lung transplantation [J].
Aringer, M ;
Kiener, HP ;
Koeller, MD ;
Artemiou, O ;
Zuckermann, A ;
Wieselthaler, G ;
Klepetko, W ;
Seidl, G ;
Kainberger, F ;
Bernecker, P ;
Smolen, JS ;
Pietschmann, P .
BONE, 1998, 23 (05) :485-488
[4]   Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation [J].
Aris, RM ;
Lester, GE ;
Renner, JB ;
Winders, A ;
Blackwood, AD ;
Lark, RK ;
Ontjes, DA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (03) :941-946
[5]   Severe osteoporosis before and after lung transplantation [J].
Aris, RM ;
Neuringer, IP ;
Weiner, MA ;
Egan, TM ;
Ontjes, D .
CHEST, 1996, 109 (05) :1176-1183
[6]   Increased rate of fractures and severe kyphosis: Sequelae of living into adulthood with cystic fibrosis [J].
Aris, RM ;
Renner, JB ;
Winders, AD ;
Buell, HE ;
Riggs, DB ;
Lester, GE ;
Ontjes, DA .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (03) :186-193
[7]   Treatment of established bone loss after renal transplantation with etidronate [J].
Arlen, DJ ;
Lambert, K ;
Ioannidis, G ;
Adachi, JD .
TRANSPLANTATION, 2001, 71 (05) :669-673
[8]  
ARNOLD JC, 1992, TRANSPLANT P, V24, P2709
[9]   Risk factors for vertebral fractures in renal osteodystrophy [J].
Atsumi, K ;
Kushida, K ;
Yamazaki, K ;
Shimizu, S ;
Ohmura, A ;
Inoue, T .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (02) :287-293
[10]  
Awumey E, 1999, BIOCHEM BIOPH RES CO, V254, P148